Company / Operating Income per Share
Decoy Therapeutics Inc. Operating Income per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$7.08
FY2022
5-year range
-$7.08 / -$0.33
FY2018-FY2022
Trend
-2065.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -2065% YoY in FY2022, a notable deviation from the 6-year average annual change of -385%.
Based on SEC 10-K filings.
-7.08 in FY2022.
Declined from $-1.83 to $-7.08 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, operating income per share decreased 2065.0% year-over-year.
- Peak operating income per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$7.08 | -2065.0% |
| FY2021 | -$0.33 | +82.1% |
| FY2020 | -$1.83 | -121.1% |
| FY2019 | -$0.83 | +63.0% |
| FY2018 | -$2.24 | -28.7% |
| FY2017 | -$1.74 | -241.4% |
| FY2016 | -$0.51 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026